Delivery Order SPE2DB22D1106-SPE2DB24FETZ0

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,279.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 500 capsules of the pharmaceutical drug Ramipril 10 mg. The contract has a ceiling value of $1,279.26 and is set to be completed by September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide essential medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of 4,566,417,874 units of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The $1,949.35 firm fixed-price delivery order has a completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of 4,564,107,965 units of Ramipril 10 mg capsules in 100-count packages to the Defense Logistics Agency (DLA). The $3,075.33 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 28, 2024, with a completion date of March 29, 2024. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,616.20 firm fixed-price delivery order covers the supply of RAMIPRIL 10 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,779.78 firm fixed-price delivery order is for the supply of 500 capsules of Ramipril 10 mg, a medication used to treat high blood pressure and heart failure. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999...
This federal contract award is for the delivery of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $4,564.62, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ramipril 10 mg capsules. The $3,896.40 firm fixed price contract has an ultimate completion date of August 22, 2024. As this is a delivery order, it is likely part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 for the supply of a comprehensive range of medical...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules in quantities of 500 capsules per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 31, 2024. The contract has a ceiling value of $2,353.45 and a completion date of February 1, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating it was...
The U.S. Defense Logistics Agency (DLA) awarded a $1,890.68 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,565,295,981 units of the drug Lotrel 10-20 mg capsules in 100-count packages. The contract has a period of performance through July 31, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,874.04, is for the delivery of Lotrel 10-20 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through September 21, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FETZ0
    Delivery Order

This federal contract award, valued at $3,129.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,730,616 capsules of the prescription medication Ramipril 10 mg, with a completion date of May 29, 2024. This contract is a Delivery Order and utilizes a Firm Fixed Price pricing type, and it was not set aside for any specific business category.

AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/27/24, 9:30 AM